Thomas Blankenburg

Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel

Wolfgang Schuette, S. Nagel, Thomas Blankenburg et al. · Journal of Clinical Oncology · 2005 · 181 citations

A Multicenter Phase II Study of Gemcitabine and Oxaliplatin for Malignant Pleural Mesothelioma

Wolfgang Schuette, Thomas Blankenburg, Kathrin Lauerwald et al. · Clinical Lung Cancer · 2003 · 52 citations

Malignant Pleural Mesothelioma, Malignant Disease, Medicine +5

Multicenter Randomized Trial for Stage IIIB/IV Non–Small-Cell Lung Cancer Using Every-3-Week Versus Weekly Paclitaxel/Carboplatin

Wolfgang Schuette, Thomas Blankenburg, Wolf Guschall et al. · Clinical Lung Cancer · 2006 · 46 citations

Medicine, Metronomic Therapy, Clinical Trials +8

Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer

Wolfgang Schuette, S. Nagel, Stefan Juergens et al. · Clinical Lung Cancer · 2005 · 28 citations

Oncology, Phase Ii Trial, Medicine +7

Survival of Hypercapnic Patients with COPD and Obesity Hypoventilation Syndrome Treated with High Intensity Non Invasive Ventilation in the Daily Routine Care

Thomas Blankenburg, Christin Benthin, S Pohl et al. · The Open Respiratory Medicine Journal · 2017 · 21 citations · Full text